IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model

International Archives of Allergy and Immunology

Volumn 149, Issue 4, 2009, Pages 315-322

  Akiyama, Kosuke ^a   Karaki, Masayuki ^a   Kobayshi, Ryuichi ^a   Dobashi, Hiroaki ^a   Ishida, Toshihiko ^a   Mori, Nozomu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Allergic rhinitis; Eosinophils; Fexofenadine; Interleukin 16; Nasal mucosa; Ovalbumin sensitized mouse; Ramatoban

Indexed keywords

ANTIALLERGIC AGENT; DRUG VEHICLE; FEXOFENADINE; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 16; OVALBUMIN; PROSTAGLANDIN D2; RAMATROBAN; ANTITHROMBOCYTIC AGENT; CARBAZOLE DERIVATIVE; DRUG DERIVATIVE; SULFONAMIDE; TERFENADINE;

ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; FEMALE; HISTAMINE RELEASE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NOSE MUCOSA; NOSE SEPTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SNEEZING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; DISEASE MODEL; DRUG EFFECT; EOSINOPHIL; IMMUNOLOGY; METABOLISM; PERENNIAL RHINITIS;

ANIMALS; ANTI-ALLERGIC AGENTS; CARBAZOLES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN E; INTERLEUKIN-16; MICE; MICE, INBRED BALB C; NASAL MUCOSA; OVALBUMIN; PLATELET AGGREGATION INHIBITORS; RHINITIS, ALLERGIC, PERENNIAL; SULFONAMIDES; TERFENADINE;

EID: 62349083088     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000205577     Document Type: Article

References (33)

1. Cruikshank W, Center DM: Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J Immunol 1982;128:2569-2574.
2. Center DM, Kornfeld H, Cruikshank WW: Interleukin 16 and its function as a CD4 ligand. Immunol Today 1996;17:476-481. (Pubitemid 26323317)
3. Laberge S, Ernst P, Ghaffar O, Cruikshank WW, Kornfeld H, Center DM, Hamid Q: Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma. Am J Respir Cell Mol Biol 1997;17:193-202. (Pubitemid 127499018)
4. Franz JK, Kolb SA, Hummel KM, Lahrtz F, Neidhart M, Aicher WK, Pap T, Gay RE, Fontana A, Gay S: Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis. Eur J Immunol 1998;28:2661-2671. (Pubitemid 28425225)
5. Laberge S, Ghaffar O, Boguniewicz M, Center DM, Leung DY, Hamid Q: Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immunol 1998;102:645-650. (Pubitemid 28487942)
6. Yoshimoto T, Wang CR, Yoneto T, Matsuzawa A, Cruikshank WW, Nariuchi H: Role of IL-16 in delayed-type hypersensitivity reaction. Blood 2000;95:2869-2874. (Pubitemid 30235897)
7. Cruikshank WW, Kornfeld H, Center DM: Interleukin-16. J Leukoc Biol 2000;67:757-766.
8. Mathy NL, Bannert N, Norley SG, Kurth R: Cutting edge: CD4 is not required for the functional activity of IL-16. J Immunol 2000;164:4429-4432. (Pubitemid 30238036)
9. Lynch EL, Little FF, Wilson KC, Center DM, Cruikshank WW: Immunomodulatory cytokines in asthmatic inflammation. Cytokine Growth Factor Rev 2003;14:489-502.
10. De Bie JJ, Jonker EH, Henricks PA, Hoevenaars J, Little FF, Cruikshank WW, Nijkamp FP, Van Oosterhout AJ: Exogenous interleukin- 16 inhibits antigen-induced airway hyper-reactivity, eosinophilia and Th2-type cytokine production in mice. Clin Exp Allergy 2002;32:1651-1658. (Pubitemid 35370543)
11. El Bassam S, Pinsonneault S, Kornfeld H, Ren F, Menezes J, Laberge S: Interleukin-16 inhibits interleukin-13 production by allergen-stimulated blood mononuclear cells. Immunology 2006;117:89-96.
12. Laberge S, Durham SR, Ghaffar O, Rak S, Center DM, Jacobson M, Hamid Q: Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment. J Allergy Clin Immunol 1997;100:569-574. (Pubitemid 27441318)
13. Karaki M, Dobashi H, Kobayashi R, Tokuda M, Ishida T, Mori N: Expression of interleukin-16 in allergic rhinitis. Int Arch Allergy Immunol 2005;138:67-72.
14. Hessel EM, Cruikshank WW, Van Ark I, De Bie JJ, Van Esch B, Hofman G, Nijkamp FP, Center DM, Van Oosterhout AJ: Involvement of IL-16 in the induction of airway hyper-responsiveness and up-regulation of IgE in a murine model of allergic asthma. J Immunol 1998;160:2998-3005. (Pubitemid 28136756)
15. Pullerits T, Linden A, Malmhall C, Lotvall J: Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis. Allergy 2001;56:871-877. (Pubitemid 32800394)
16. Sugimoto Y, Kawamoto E, Chen Z, Kamei C: A new model of allergic rhinitis in rats by topical sensitization and evaluation of H (1)-receptor antagonists. Immunopharmacology 2000;48:1-7.
17. Saito H, Howie K, Wattie J, Denburg A, Ellis R, Inman MD, Denburg JA: Allergen-induced murine upper airway inflammation: local and systemic changes in murine experimental allergic rhinitis. Immunology 2001;104:226-234. (Pubitemid 32989523)
18. Watanabe N, Matsuda E, Masuda A, Nariai K, Shibasaki T: The effects of fexofenadine on eosinophilia and systemic anaphylaxis in mice infected with Trichinella spiralis . Int Immunopharmacol 2004;4:367-375. (Pubitemid 38375970)
19. Kayasuga R, Sugimoto Y, Watanabe T, Kamei C: Participation of chemical mediators other than histamine in nasal allergy signs: a study using mice lacking histamine H(1) receptors. Eur J Pharmacol 2002;449:287-291. (Pubitemid 34886485)
20. Masuda K, Katoh N, Soga F, Kishimoto S: The role of interleukin-16 in murine contact hypersensitivity. Clin Exp Immunol 2005;140:213-219. (Pubitemid 40559147)
21. Rasband WS: ImageJ. Bethesda, US National Institutes of Health, 1997-2007. http://rsb. info.nih.gov/ij/.
22. Lim KG, Wan HC, Bozza PT, Resnick MB, Wong DT, Cruikshank WW, Kornfeld H, Center DM, Weller PF: Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol 1996;156:2566-2570. (Pubitemid 26091586)
23. Cruikshank WW, Long A, Tarpy RE, Komfeld H, Carroll MP, Teran L, Holgate ST, Center DM: Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am J Respir Cell Mol Biol 1995;13:738-747.
24. Mashikian MV, Tarpy RE, Saukkonen JJ, Lim KG, Fine GD, Cruikshank WW, Center DM: Identification of IL-16 as the lymphocyte chemotactic activity in the bronchoalveolar lavage fluid of histamine-challenged asthmatic patients. J Allergy Clin Immunol 1998;101:786-792. (Pubitemid 28293186)
25. Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Reale M, Barbacane RC, Castellani ML, Mortari U, Boucher W, Letourneau R, Theoharides TC: Interleukin-16 network in inflammation and allergy. Allergy Asthma Proc 2002;23:103-108.
26. Bandeira-Melo C, Sugiyama K, Woods LJ, Phoofolo M, Center DM, Cruikshank WW, Weller PF: IL-16 promotes leukotriene C (4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. J Immunol 2002;168:4756-4763. (Pubitemid 34441384)
27. Laberge S, Pinsonneault S, Ernst P, Olivenstein R, Ghaffar O, Center DM, Hamid Q: Phenotype of IL-16-producing cells in bronchial mucosa: evidence for the human eosinophil and mast cell as cellular sources of IL-16 in asthma. Int Arch Allergy Immunol 1999;119:120-125. (Pubitemid 29304467)
28. de Bie JJ, Henricks PA, Cruikshank WW, Hofman G, Nijkamp FP, van Oosterhout AJ: Effect of interleukin-16-blocking peptide on parameters of allergic asthma in a murine model. Eur J Pharmacol 1999;383:189-196.
29. Krug N, Cruikshank WW, Tschernig T, Erpenbeck VJ, Balke K, Hohlfeld JM, Center DM, Fabel H: Interleukin 16 and T-cell chemoattractant activity in bronchoalveolar lavage 24 h after allergen challenge in asthma. Am J Respir Crit Care Med 2000;162:105-111. (Pubitemid 30469806)
30. McFadden C, Morgan R, Rahangdale S, Green D, Yamasaki H, Center D, Cruikshank W: Preferential migration of T regulatory cells induced by IL-16. J Immunol 2007;179:6439-6445.
31. Gelfand EW, Cui ZH, Takeda K, Kanehiro A, Joetham A: Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponsiveness. J Allergy Clin Immunol 2002;110:85-95. (Pubitemid 36132733)
32. Xue L, Gyles SL, Wettey WR, Gazi L, Townsend E, Hunter MG, Pettipher R: Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 2005;175:6531-6536. (Pubitemid 41598895)
33. Ashenager MS, Grgela T, Aragane Y, Kawada A: Inhibition of cytokine-induced expression of T-cell cytokines by antihistamines. J Investig Allergol Clin Immunol 2007;17:20-26. (Pubitemid 46280157)